50242-080 : Lucentis 10 mg/ml Intravitreal Injection, Solution


NDC: 50242-080
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Lucentis
Dosage Form: Intravitreal Injection, Solution
Application #: BLA125156
Rev. Date: 


NDC Package Codes:

  • 50242-080-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑080‑01) > .05 ML IN 1 VIAL, SINGLE‑USE
  • 50242-080-02: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑080‑02) > .05 ML IN 1 VIAL, SINGLE‑USE
  • 50242-080-03: 1 SYRINGE, GLASS IN 1 PACKET (50242‑080‑03) > .05 ML IN 1 SYRINGE, GLASS
  • 50242-080-86: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑080‑86) > .05 ML IN 1 VIAL, SINGLE‑USE
  • 50242-080-88: 1 SYRINGE, GLASS IN 1 PACKET (50242‑080‑88) > .05 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Ranibizumab

Dosage Strength:

  • 10 mg/mL

Pharmaceutical Classes:

  • Vascular Endothelial Growth Factor Receptor Inhibitors [MoA]
  • Vascular Endothelial Growth Factor-directed Antibody [EPC]
  • Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 50242-082 Lucentis 6 mg/ml Intravitreal Injection, Solution by Genentech, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-080 QR Code

< Prev: 50242-078Next: 50242-082 >

Related Discussions:

Avastin/ lucentis side effecis
After eye injections of avastin i was switched to lucentis. i then had 2 tia's and stopped treatment. I had been exp... 1 reply
macugen lucentis
masculen degeneration...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.